Superiority trial for the development of an ideal method for the closure of midline abdominal wall incisions to reduce the incidence of wound complications after elective gastroenterological surgery: study protocol for a randomized controlled trial

Trials. 2024 May 17;25(1):327. doi: 10.1186/s13063-024-08167-w.

Abstract

Background: The recent guidelines from the European and American Hernia Societies recommend a continuous small-bite suturing technique with slowly absorbable sutures for fascial closure of midline abdominal wall incisions to reduce the incidence of wound complications, especially for incisional hernia. However, this is based on low-certainty evidence. We could not find any recommendations for skin closure. The wound closure technique is an important determinant of the risk of wound complications, and a comprehensive approach to prevent wound complications should be developed.

Methods: We propose a single-institute, prospective, randomized, blinded-endpoint trial to assess the superiority of the combination of continuous suturing of the fascia without peritoneal closure and continuous suturing of the subcuticular tissue (study group) over that of interrupted suturing of the fascia together with the peritoneum and interrupted suturing of the subcuticular tissue (control group) for reducing the incidence of midline abdominal wall incision wound complications after elective gastroenterological surgery with a clean-contaminated wound. Permuted-block randomization with an allocation ratio of 1:1 and blocking will be used. We hypothesize that the study group will show a 50% reduction in the incidence of wound complications. The target number of cases is set at 284. The primary outcome is the incidence of wound complications, including incisional surgical site infection, hemorrhage, seroma, wound dehiscence within 30 days after surgery, and incisional hernia at approximately 1 year after surgery.

Discussion: This trial will provide initial evidence on the ideal combination of fascial and skin closure for midline abdominal wall incision to reduce the incidence of overall postoperative wound complications after gastroenterological surgery with a clean-contaminated wound. This trial is expected to generate high-quality evidence that supports the current guidelines for the closure of abdominal wall incisions from the European and American Hernia Societies and to contribute to their next updates.

Trial registration: UMIN-CTR UMIN000048442. Registered on 1 August 2022. https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055205.

Keywords: Continuous suture; Fascial closure; Incisional hernia; Interrupted suture; Midline abdominal wall incision; Peritoneal closure; Skin closure; Surgical site infection; Wound complication.

Publication types

  • Clinical Trial Protocol

MeSH terms

  • Abdominal Wall* / surgery
  • Abdominal Wound Closure Techniques* / adverse effects
  • Digestive System Surgical Procedures* / adverse effects
  • Digestive System Surgical Procedures* / methods
  • Elective Surgical Procedures* / adverse effects
  • Elective Surgical Procedures* / methods
  • Equivalence Trials as Topic
  • Humans
  • Incidence
  • Incisional Hernia* / epidemiology
  • Incisional Hernia* / etiology
  • Incisional Hernia* / prevention & control
  • Prospective Studies
  • Randomized Controlled Trials as Topic
  • Surgical Wound Infection* / epidemiology
  • Surgical Wound Infection* / etiology
  • Surgical Wound Infection* / prevention & control
  • Suture Techniques* / adverse effects
  • Time Factors
  • Treatment Outcome
  • Wound Healing